Floatz logo

Pegylated Interferon Alfa-2B

Chronic Hepatitis C

Center For Hepatitis C, Atlanta, GAPhase 4 / ApprovedDormant
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Chronic Hepatitis C cohort.

Asset / SponsorPhaseRating
OMBITASVIR
Ain Shams University
Phase 3A
PARITAPREVIR
Ain Shams University
Phase 3A
Ribavirin
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
Phase 4A
Dasabuvir
AbbVie
Phase 3A
Sofosbuvir
Peking University First Hospital
Phase 4A

View all 50 →

Same molecule, other indications

Pegylated Interferon Alfa-2B is also rated in:

chronic hepatitis C virus infectionDormant
BB
Indicative ·
64 / 100
View asset →
disease related to solid organ transplantationDormant
BB
Indicative ·
64 / 100
View asset →
adult T-cell leukemia/lymphomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →